EGFR and non-small cell lung carcinoma: In EGFR-mutant non-small cell lung cancer, third-generation EGFR-TKIs inevitably select for on-target mutations (e.g., C797S) and bypass signaling (e.g., MET/ERBB), undermining long-term control [12, 13].